StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
297
This month
5
This week
2
This year
41
Publishing Date
2024 - 03 - 13
3
2024 - 03 - 04
4
2024 - 02 - 27
3
2024 - 02 - 23
2
2024 - 02 - 14
3
2024 - 01 - 02
2
2023 - 12 - 12
2
2023 - 12 - 09
2
2023 - 11 - 21
2
2023 - 11 - 09
2
2023 - 11 - 07
2
2023 - 09 - 25
3
2023 - 06 - 27
2
2023 - 04 - 17
2
2023 - 04 - 03
2
2023 - 03 - 29
4
2023 - 02 - 24
2
2023 - 02 - 22
4
2023 - 01 - 24
2
2022 - 12 - 13
2
2022 - 11 - 21
3
2022 - 11 - 03
4
2022 - 09 - 27
2
2022 - 08 - 16
2
2022 - 08 - 10
2
2022 - 08 - 08
3
2022 - 08 - 05
2
2022 - 06 - 10
4
2022 - 06 - 09
2
2022 - 06 - 06
2
2022 - 05 - 12
2
2022 - 04 - 13
2
2022 - 03 - 29
3
2022 - 03 - 14
2
2022 - 03 - 08
2
2022 - 02 - 24
3
2022 - 01 - 25
2
2022 - 01 - 03
2
2021 - 12 - 13
2
2021 - 12 - 11
2
2021 - 12 - 01
2
2021 - 09 - 21
2
2021 - 07 - 22
2
2021 - 07 - 21
2
2021 - 06 - 22
3
2021 - 06 - 02
3
2021 - 06 - 01
2
2021 - 05 - 21
3
2021 - 05 - 19
2
2021 - 05 - 11
2
2021 - 05 - 03
2
2021 - 04 - 13
3
2021 - 03 - 07
1
2021 - 03 - 02
2
2021 - 02 - 26
1
2021 - 02 - 25
1
2021 - 02 - 10
1
2021 - 01 - 27
1
2021 - 01 - 05
1
2020 - 12 - 15
1
Sector
Communications
2
Electronic technology
1
Finance
26
Health technology
297
Manufacturing
5
N/a
1
Non-energy minerals
3
Process industries
1
Producer manufacturing
1
Professional, scientific, and technical services
2
Technology services
1
Tags
Abbvie
5
Agreement
4
Alliances
5
Als
2
Announcement
10
Antibody
11
Application
8
Approval
4
Approved
3
Asco
2
Authorization
3
Cancer
19
Cd20
14
Ces
3
Chmp
3
Collaboration
4
Conference
15
Darzalex
13
Drug
10
Duobody
14
Earnings
3
Employee
13
Europe
10
Events
4
Fda
7
Financial
8
Financial results
3
Food
5
Global
8
Grant
18
Granted
6
Growth
3
Immunotherapy
3
Japan
3
License
14
Lung cancer
3
Management
3
Market
3
Meeting
13
Money
3
N/a
256
People
3
Phase 1
3
Phase 2
4
Positive
6
Presentation
3
Program
33
Report
8
Research
7
Results
23
Review
4
Sales
12
Technology
3
Therapeutics
6
Therapy
6
Tivdak
8
Topline
4
Treatment
14
Trial
9
Update
5
Entities
3m company
1
Abbvie inc.
30
Adc therapeutics sa
8
Amgen inc.
11
Antares pharma, inc.
1
Argenx se
2
Arvinas, inc.
1
Astellas pharma inc
1
Astrazeneca plc
2
Avantor, inc.
1
Bausch health companies inc.
1
Becton, dickinson and company
1
Bio-techne corp
1
Biogen inc.
1
Biomarin pharmaceutical inc.
2
Biontech se
8
Bolt biotherapeutics inc
4
Bristol-myers squibb company
6
Cerevel therapeutics holdings, inc.
2
Curevac n.v.
2
Danaher corporation
1
Eli lilly and company
2
First bank
18
Flsmidth & co. a/s
3
Garmin ltd.
1
Genmab a/s
297
Geron corporation
1
Gilead sciences, inc.
4
Glaxosmithkline plc
7
Greenlight biosciences inc
2
Halozyme therapeutics, inc.
4
Icon plc
1
Immunome, inc.
1
Infineon technologies ag
1
Intellia therapeutics, inc.
3
Jazz pharmaceuticals plc
2
Johnson & johnson
57
Karuna therapeutics, inc.
1
Ligand pharmaceuticals incorporated
1
Matinas biopharma holdings, inc.
1
Medies
1
Medtronic plc
1
Mercadolibre, inc.
1
Mirati therapeutics, inc.
1
Morgan stanley
6
Novartis ag
21
Novo nordisk a/s
4
Novocure limited
1
Obseva sa
2
Orange
2
Pfizer, inc.
4
Sanofi
11
Seagen inc.
17
Shattuck labs, inc.
1
Spectrum pharmaceuticals, inc.
1
Takeda pharmaceutical company limited
3
Teva pharmaceutical industries ltd
1
Turning point therapeutics, inc.
1
West pharmaceutical services, inc.
1
Zai lab limited
3
Symbols
AAPL
1197
ABB
1426
ABBV
1024
ABLZF
1165
ABT
1786
ACN
600
AMGN
742
ARVL
4293
AZN
664
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7186
FRBA
598
GE
915
GLAXF
657
GOOG
1279
GOOGL
1278
GSK
883
HON
1783
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4575
LLY
1708
LTUM
970
LYV
717
MDT
1285
MMM
938
MS
4283
MSFT
1200
MT
589
NOC
589
NOK
900
NOKBF
974
NVO
631
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1476
SAPGF
1230
SNOW
794
SNY
4534
SNYNF
3592
TEVJF
630
TMO
1622
VZ
1213
XYF
676
Exchanges
Amex
1
Nasdaq
297
Nyse
109
Crawled Date
2024 - 03 - 13
3
2024 - 03 - 04
4
2024 - 02 - 27
3
2024 - 02 - 23
2
2024 - 02 - 14
3
2024 - 01 - 23
2
2024 - 01 - 02
2
2023 - 12 - 12
2
2023 - 12 - 09
2
2023 - 11 - 21
2
2023 - 11 - 09
2
2023 - 11 - 07
2
2023 - 09 - 25
3
2023 - 06 - 27
2
2023 - 04 - 17
2
2023 - 04 - 03
2
2023 - 03 - 29
4
2023 - 02 - 24
2
2023 - 02 - 22
4
2023 - 01 - 24
2
2022 - 12 - 13
2
2022 - 12 - 12
2
2022 - 11 - 21
3
2022 - 11 - 03
4
2022 - 09 - 27
2
2022 - 08 - 16
2
2022 - 08 - 10
2
2022 - 08 - 08
3
2022 - 08 - 05
2
2022 - 06 - 10
4
2022 - 06 - 09
2
2022 - 06 - 06
2
2022 - 05 - 12
2
2022 - 04 - 13
2
2022 - 03 - 29
3
2022 - 03 - 14
2
2022 - 03 - 08
2
2022 - 02 - 24
3
2022 - 01 - 25
2
2022 - 01 - 04
2
2021 - 12 - 14
2
2021 - 12 - 11
2
2021 - 12 - 01
2
2021 - 09 - 21
2
2021 - 07 - 22
2
2021 - 07 - 21
2
2021 - 06 - 22
3
2021 - 06 - 02
3
2021 - 06 - 01
2
2021 - 05 - 21
3
2021 - 05 - 11
2
2021 - 05 - 03
2
2021 - 04 - 13
3
2021 - 03 - 02
2
2021 - 02 - 26
1
2021 - 02 - 25
1
2021 - 02 - 11
1
2021 - 01 - 27
1
2021 - 01 - 05
1
2020 - 12 - 15
1
Crawled Time
00:00
7
00:20
1
01:00
4
02:00
1
05:00
1
06:00
3
07:00
2
08:00
18
09:00
7
10:00
9
10:41
1
11:00
22
12:00
19
12:01
1
12:15
1
12:20
2
12:30
4
13:00
11
13:15
1
13:20
2
13:30
1
14:00
12
14:15
3
14:20
5
14:30
1
15:00
10
15:15
2
15:20
4
15:30
1
16:00
7
16:20
5
17:00
20
18:00
14
19:00
26
20:00
12
20:20
4
20:25
1
21:00
30
22:00
11
22:01
1
23:00
9
23:01
1
Source
shattucklabs.com
1
www.biospace.com
41
www.curevac.com
1
www.globenewswire.com
227
www.prnewswire.com
27
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
GMAB
save search
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
Published:
2024-04-16
(Crawled : 11:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-0.35%
|
O:
4.94%
H:
0.0%
C:
-3.66%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-2.16%
|
O:
-2.09%
H:
0.0%
C:
0.0%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-3.09%
|
O:
-1.29%
H:
1.91%
C:
1.27%
darzalex
sales
first
for
Transactions in Connection with Share Buy-back Program Genmab
Published:
2024-04-15
(Crawled : 08:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-3.47%
|
O:
1.54%
H:
0.0%
C:
-4.6%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-4.04%
|
O:
-0.98%
H:
0.0%
C:
0.0%
program
Transactions in Connection with Share Buy-back Program
Published:
2024-04-08
(Crawled : 10:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-4.17%
|
O:
-0.16%
H:
3.73%
C:
-0.3%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-4.26%
|
O:
0.07%
H:
0.37%
C:
0.13%
program
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
Published:
2024-04-03
(Crawled : 06:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-6.17%
|
O:
-1.12%
H:
0.58%
C:
-1.34%
MS
|
News
0 d
|
$90.26
0.2%
0.0%
6.7M
|
Finance
|
-2.2%
|
O:
0.26%
H:
1.45%
C:
0.05%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-4.77%
|
O:
-2.04%
H:
1.12%
C:
-0.17%
acquisition
Transactions in Connection with Share Buy-back Program
Published:
2024-04-02
(Crawled : 08:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-4.97%
|
O:
-0.66%
H:
3.74%
C:
1.95%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-4.05%
|
O:
0.55%
H:
1.37%
C:
0.2%
program
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
Transactions in Connection with Share Buy-back Program
Published:
2024-03-25
(Crawled : 13:30)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-5.7%
|
O:
2.32%
H:
0.0%
C:
-1.08%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-4.65%
|
O:
0.03%
H:
0.57%
C:
0.17%
program
Bavarian Nordic A/S – Notice Convening Annual General Meeting
Published:
2024-03-21
(Crawled : 11:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-3.0%
|
O:
0.03%
H:
3.03%
C:
1.75%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-6.83%
|
O:
-0.03%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-3.83%
|
O:
0.3%
H:
0.0%
C:
0.0%
NTLA
|
$21.3
-0.93%
-0.94%
1.1M
|
Health Technology
|
-23.25%
|
O:
2.12%
H:
0.6%
C:
-2.54%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-3.09%
|
O:
1.19%
H:
0.47%
C:
-0.77%
meeting
Completion of share buy-back program
Published:
2024-03-18
(Crawled : 10:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-6.82%
|
O:
-0.76%
H:
0.6%
C:
-0.66%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-4.71%
|
O:
0.1%
H:
0.13%
C:
-0.93%
program
Genmab Announces Initiation of Share Buy-Back Program
Published:
2024-03-15
(Crawled : 12:30)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-8.28%
|
O:
0.34%
H:
0.0%
C:
-1.89%
MS
|
News
0 d
|
$90.26
0.2%
0.0%
6.7M
|
Finance
|
1.77%
|
O:
-0.7%
H:
0.98%
C:
-0.11%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-5.84%
|
O:
-0.59%
H:
0.33%
C:
-0.6%
program
Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab
Published:
2024-03-13
(Crawled : 21:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-10.22%
|
O:
1.64%
H:
0.0%
C:
-3.69%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-8.97%
|
O:
-0.26%
H:
0.0%
C:
-3.07%
FRBA
|
News
|
$12.14
0.66%
0.66%
51K
|
Finance
|
-5.9%
|
O:
-0.39%
H:
0.0%
C:
-2.26%
grant
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Published:
2024-03-13
(Crawled : 21:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-10.22%
|
O:
1.64%
H:
0.0%
C:
-3.69%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-8.97%
|
O:
-0.26%
H:
0.0%
C:
-3.07%
Passing of Genmab A/S’ Annual General Meeting
Published:
2024-03-13
(Crawled : 15:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-9.78%
|
O:
3.45%
H:
0.24%
C:
-2.87%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-9.23%
|
O:
0.92%
H:
0.5%
C:
-1.2%
meeting
Transactions in connection with share buy-back program
Published:
2024-03-11
(Crawled : 10:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-5.89%
|
O:
4.41%
H:
1.32%
C:
0.27%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-5.84%
|
O:
2.21%
H:
2.71%
C:
2.29%
program
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Published:
2024-03-04
(Crawled : 18:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-0.9%
|
O:
-0.17%
H:
2.05%
C:
0.64%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
0.07%
|
O:
1.16%
H:
0.21%
C:
-0.31%
Kate Sasser
Published:
2024-03-04
(Crawled : 12:30)
- shattucklabs.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-3.1%
|
O:
0.66%
H:
0.0%
C:
-2.86%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-2.59%
|
O:
-2.73%
H:
1.12%
C:
0.07%
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
Published:
2024-03-04
(Crawled : 12:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-3.1%
|
O:
0.66%
H:
0.0%
C:
-2.86%
STTK
|
$10.11
0.9%
0.89%
430K
|
Health Technology
|
3.83%
|
O:
3.94%
H:
0.0%
C:
-5.58%
IMNM
|
$17.175
-1.18%
-1.19%
850K
|
Health Technology
|
-32.5%
|
O:
0.98%
H:
0.0%
C:
-3.74%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-2.59%
|
O:
-2.73%
H:
1.12%
C:
0.07%
Transactions in connection with share buy-back program
Published:
2024-03-04
(Crawled : 10:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-3.1%
|
O:
0.66%
H:
0.0%
C:
-2.86%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-2.59%
|
O:
-2.73%
H:
1.12%
C:
0.07%
program
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Published:
2024-03-01
(Crawled : 23:00)
- globenewswire.com
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
Email alert
Add to watchlist
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Published:
2024-02-29
(Crawled : 16:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
2.16%
|
O:
2.52%
H:
0.0%
C:
-1.27%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
3.11%
|
O:
1.88%
H:
0.25%
C:
-1.49%
← Previous
1
2
3
4
5
6
7
8
9
…
14
15
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.